Background: Macrophages can be converted in vitro into immunoregulatory M2b
| INTRODUCTION
In immediate-type allergy, a particular Th2 cytokine microenvironment is established by inflammatory cytokines such as IL-4, IL-5, and IL-13.
These cytokines induce allergen-specific IgE, eosinophilia, mucus production, and the recruitment of inflammatory cells to inflamed tissues. [1] [2] [3] They polarize monocytes and macrophages into alternatively activated M2a macrophages typically characterized by downregulated expression of the hemoglobin-haptoglobin scavenger receptor (CD163) 4, 5 and upregulated expression of mannose receptor 1 (CD206) as well as of the B7-2 costimulatory protein CD86. The CD86 upregulation is supported by basophil-and mast cell-derived IL-4 as shown for allergic pulmonary diseases. 6 Moreover, these M2a macrophages secrete cytokines such as IL-1 receptor antagonist (IL-1ra) 7 and chemokines such as the pulmonary and activation-regulated chemokine (PARC; CCL18), the macrophage-derived chemokine (MDC; CCL22), and the thymus and activation-regulated chemokine (TARC; CCL17). 8 Whereas the symptoms of allergic reactions can be combated by different pharmacological treatments, allergen immunotherapy (AIT) represents the only curative approach in type I allergy. 9 AIT results in longterm clinical benefits, and numerous publications highlight the induction of cellular responses within regulatory T cells (Treg), especially inducible IL-10-and TGF-β-producing type 1 Treg (Tr1), and regulatory B cells (Bregs) as mechanisms of inducible tolerance. 9, 10 Bregs are not only a source of IL-10, but they also sense IL-10 as a switching factor for IgG4 production. 11 This is important as IgG4 is a hallmark of AIT, although its tolerogenic function is still insufficiently understood. 10 While it is accepted that Tregs and Bregs with IL-10 have a critical role in dampening the allergic inflammatory response in AIT, the role of macrophages in this process is not entirely defined. In particular, the M2b macrophages could take part in tolerance induction. M2b macrophages are specifically characterized by the secretion of CCL1 chemokine, 12 a ligand of the cognate chemokine receptor CCR8. 13, 14 Notably, CCR8 is not only essential for maintaining the M2b characteristics, it is also expressed by CCR8 + FOXP3 + Treg cells. 15 These master drivers of immune regulation could, therefore, be ignited by macrophages via CCL1 and CCR8.
Decisive for the present study were the observations that immune complexes (IC), without further specification, were compulsory to differentiate the M2b subtype from monocyte-derived macrophages in vitro. 12, 16 When recently subclass-specific effects were addressed on M1 macrophages, IgG4 like IgG1 inhibited IFNγ signaling via FcγRI, favoring an M2-like phenotype. 17 When treating allergy, more or less the immunological opposite is desired, which is conversion from pro-allergic M2a to M2b macrophages.
Our hypothesis combined all this background information considering the possibility to convert the pro-allergic M2a subtype, highly present in the Th2 environment, into an immunoregulatory M2b-like subtype. We (a) refined the original method, in which undefined immune complexes were applied for activating M2a macrophages, by using precisely defined immune complexes of subclasses IgG4 or IgG1; and (b) we applied two independent methods for the formation of such immune complexes, either plate bound or in solution.
Subsequently, we screened for cellular markers and cytokines correlating with the induction of a tolerogenic microenvironment.
| METHODS

| Reagents and antibodies
All reagents and antibodies used in this study are reported in Tables S1-S2.
G R A P H I C A L A B S T R A C T
This study highlights the central role of IgG4 in immune tolerance. The treatment of M2a with ICs consisting of IgG4 shows a considerably greater effect in promoting an M2b-like phenotype than with IgG1-containing ICs. The secretion of CCL1 and IL-10 by M2b-like macrophages is important to establish a tolerogenic microenvironment. Half of the medium was refreshed every 2-3 days ( Figure S1A -B).
| Isolation and treatment of human monocytes
The purity of monocytes was checked after 3 days, by flow cytometric analysis as CD3 
| Macrophage polarization
After 7-9 days, the cells acquired the mature macrophage characteristics. Macrophages were then removed using PBS −Ca−Mg supplemented with 2.5 mmol/L EDTA (PBS/EDTA) pH 8.0 and allowed to recover in cRPMI. Then, the cells were polarized in M2o, M2a, M2b, and M2c as described in 
| Staining and flow cytometric analysis
After 72 hours, cells incubated on IgG1-or IgG4-IC-coated plates were detached using ice-cold PBS/EDTA and washed twice with HBSS plus 3% FBS as staining buffer, for surface marker phenotypization. Then, the cells were incubated with a multicolor staining mix of monoclonal antibodies against CD14, CD86, CD11b, CD163, and CD206 or their isotype controls (BioLegend) diluted 1:100 in staining buffer for 30 minutes at 4°C followed by 2× washing with staining buffer.
For the FcγR staining, the cells were detached as described above, washed with an ice-cold staining buffer (PBS −Ca−Mg plus 1% BSA, 0.02% NaN 3 ), and then blocked with 2.4 mg/mL human IgG (Beriglobin P; CSL Behring, King of Prussia, PA, USA) in staining buffer for 30 minutes on ice. The cells were then incubated with a multicolor staining mix of primary monoclonal antibodies against CD64, CD32, and CD16 or isotype controls (as specified in Table S2 ; 
| Real-time polymerase chain reaction
The primers (Table S4) were designed using Primer-Blast tool 19 and evaluated with Beacon Designer Free Edition (Premier Biosoft, Palo Alto, CA, USA). Real-time PCR (rtPCR) was performed using the Solis Biodyne Supermix (Solis Biodyne, Tartu, Estonia) in accordance with manufacturer's recommendations. rtPCR was performed on a QuantStudio 12K Flex system (Thermo Fisher Scientific) (Data S1).
The 2 −ΔΔCt analysis was performed using the QuantStudio 12k
Flex Software v1.2.3 (Thermo Fisher Scientific) to obtain the cycle of threshold (Ct) for each sample investigated. Actin beta (ACTB) was used as reference gene. The mean fold change expression was calculated for M2a, M2a + IgG1, and M2a + IgG4.
| Graphs and statistical analysis
The graphs and the statistical analyses were performed with GraphPad Prism version 6.00 for Macintosh (GraphPad Software, La Jolla, CA, USA).
Validation of data was done by repeated-measures one-way ANOVA and Tukey multiple comparison post-hoc test. Student's t test was performed to compare the rtPCR values of M2a + IgG1 and M2a + IgG4. The level of statistical significance is defined as n.s P > 0.05 (not significant), *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
3 | RESULTS
| Surface markers clearly distinguish M2a and
M2b macrophages
The flow cytometric analyses of nine donors in four independent experiments were performed to distinguish between the different alternatively activated macrophages polarized in vitro. The analyses evaluated the surface marker expression of CD206, CD163, and the co stimulatory molecule B7-2 (CD86), considered as specific markers of M2 alternatively activated population. 8 The results showed that M2a macrophages had a higher expression of CD206 compared with M2o polarized macrophages, the CD163 expression was relatively higher in M2a macrophages than in M2b, but lower than in M2c, and the expression of CD86 was higher in M2a macrophages than in Table S5A -B).
| Contrasting cytokine expression between M2a
and M2c, and M2b
The method of choice to assess the differences between M2a proallergic and M2b immunoregulatory macrophage subpopulation is their cytokine and chemokine patterns. The results from four independent experiments were combined for statistical analysis. Repeatedmeasures one-way ANOVA statistical analysis and Tukey multiple comparison post-hoc test were performed, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, n.s. not significant Table S6 . An almost exclusive secretion of CCL1 was observed when M2a macrophages were stimulated with ICs containing IgG4 than IgG1 compared with M2a alone (Table S6 and Figure S3C ).
Therefore, ICs formed with mIgG4 also functionally drive the polarization status of pro-allergic M2a macrophages toward an M2b-like regulatory subtype. anti-inflammatory potency. This has been explained by the fact that it cannot fix complement, and that it is the only class that may be naturally bispecific due to Fab arm exchange, 23 limiting its capacity to be cross-linked by an allergen. 24 The non-inflammatory action of IgG4 is desired in allergy, but harmful in other conditions with CD32 -Fc production.
1,10
We addressed here whether IgG4 might even have a more prominent role in immune tolerance by directly influencing IL-10 production. Corresponding to the Th1-Th2 paradigm, also macrophages can functionally differentiate into M1, and M2 cells, with the M2a, b, c subtypes, which can be mimicked by in vitro stimulation protocols. 16, 27 It caught our attention that especially the tolerogenic M2b subtype is activated in the presence of IgG immune complexes, which so far were not further classified.
The study hypothesis was, therefore, that pro-allergic M2a macrophages could by immune complexes containing IgG4, as induced by AIT, be functionally converted into an immunoregulatory M2b subtype. M2b-derived secretion of CCL1 and IL-10 may contribute to the development of a tolerogenic microenvironment.
We first determined the phenotype and the secretion pattern of all in vitro polarized macrophages because of some overlap in their characteristics. For instance, the expression of CD206 that is considered high in the M2a subtype is also expressed by M2o or M2c (Figure 1A) and even by M1 cells; 5 CD163, which is medium-low expressed by M2a and in M2o subtypes, is upregulated by glucocorticoid treatment in the M2c subtype. 4, 5, 16 In accordance with previous studies, only the M2b macrophage subtype produced CCL1 chemokine and higher IL-10 levels than any other subtypes and thus had the most pronounced signature. [12] [13] [14] It is known that macrophages have a degree of plasticity, but the phenotypic and functional change in pro-allergic M2a toward an M2b-like phenotype only in the presence of IgG4, but not IgG1, was striking. This subclass-specific phenomenon was observed with complexes containing myeloma IgG4, as well as when using recombinant anti-Phl p 5 specific IgG4 when complexed to its specific allergen.
Therefore, IgG4 complexes are potent stimulators of macrophages to CCL-1 and IL-10 production and capable to turn them from a proallergic to a regulatory phenotype.
To investigate the molecular mechanism, we examined the sur- The results from three independent experiments were combined for statistical analysis. Repeatedmeasures one-way ANOVA statistical analysis and Tukey multiple comparison post-hoc test were performed, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001
IgG subclasses. 12 Our data show that IgG4-mediated FcγRII stimulation is decisive for the phenotypic and functional conversion of M2a [33] [34] [35] A Japanese genomewide association study of IgG4-RD reported three susceptibility loci consistent with an antigen-driven disease. Currently, IgG4 is rather regarded as a protective antibody in IgG4-RD, dampening the more harmful effects of IgG1. 36 In accordance, FCGR2B is considered to play a critical role in the control of IgG4-RD. 37 A recent study correlates the high expression of IgG4 from IgG4-RD sclerosing cholangitis patients' B cells with the high expression of CCL1 in the tissues and, in turn, with the recruitment of CCR8 + FOXP3 + Treg cells. 38 The high affinity of CCL1 for CCR8 as well as the emerging opinion that CCL1 is indispensable for Treg function, further emphasizes the link of CCL1 and IL-10 whit the creation of an immunoregulatory microenvironment. 15, 39 Moreover, the importance of CCL1, produced by M2b macrophages, in this process is also documented by the fact that treatment with antisense CCL1-oligonucleotide inhibited M2b macrophages to maintain their characteristics such as IL-10 production and inflammation inhibition. 13, 14 Thus, our data argue for a central role of IgG4 in immune tolerance as induced by AIT, prompting cross talk between macrophages and regulatory lymphocytes.
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